SIGA - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan SIGA Corp

Logo grafis SIGA Technologies, Inc. (SIGA)

SIGA Technologies, Inc. (SIGA) generates revenue through biosecurity deals, where the primary driver is the sale of TPOXX to strategic national stockpiles. The quarterly EPS change scale on GURU.Markets reflects profit dynamics, while 54.20 characterizes this valuation parameter. Management is successfully executing long-term obligations as it pursues global expansion. Multi-year government agreements for the supply of antiviral agents ensure revenue stability.

Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan SIGA Technologies (SIGA): kanggo periode 04.07.2022 - 16.11.2026

Ringkesan rincian data analitis SIGA Technologies, Inc. (SIGA)

- nilai pasar lan prakiraan target analis:
- statistik kapitalisasi pasar:
Analisis fundamental perusahaan:SIGA Technologies Inc - SIGA
Barang unggulan TPOXX

Long-term capital requires strict volatility control and confirmation of earnings sustainability. For biodefense leader SIGA Technologies, Inc. (SIGA), which invests in antiviral R&D, stable cash flows are critical. The quarterly EPS dynamics reflect the percentage change in net income per share relative to the previous period. Growth in this indicator confirms the effectiveness of innovation commercialization. A stable trend minimizes the risk of drawdowns during macroeconomic shocks.

Analisis pesaing

Gilead Sciences Inc (GILD) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Cidara - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan NVAX|Wutah bathi EPS kuartalan curevac.com|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Valneva Corp (VALN)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan VIR (Vir Biotechnology)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Emergent Bio EBS|Wutah bathi EPS kuartalan Atea Pharmaceuticals AVIR|IVVD - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|ENTA (Enanta Pharmaceuticals) - Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan|INO (Inovio) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|HLVX (HilleVax Inc) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|KLRS (Kalaris Therapeutics Inc.) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan DYAI (Dyadic International)|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan NNVC (NanoViricides)|TLPH (Talphera, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Cocrystal Pharma Inc COCP|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan TRAW|Dogwood Therapeutics Inc. - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Qualigen Corp|ALVR (AlloVir Bio) - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan VBI Vaccines, Inc.|VIRI (virios.com) - Wutah bathi EPS kuartalan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan VXRT (Vaxart, Inc.)